Hello friends,

Does anyone have an HRSA supported comprehensive hemophilia diagnostic
treatment center and participate in the 340B drug purchase program? I am
primarily interested in how you treat the program income from an
accounting perspective and what, if any, types of indirect costs (i.e.,
clinical practice, organized research, etc.) you use to calculate the
net program income. Any advice you can provide is greatly appreciated.

Thanks much,
Patty Hagen, Ph.D.
Associate Provost
Saint Louis University

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================